ClinicalTrials.Veeva

Menu

Efficacy and Safety of Resveratrol and Lipoic Acid Transdermal Patch for Lipolysis in Overweight Volunteers

C

Chulalongkorn University

Status

Completed

Conditions

Lipolysis

Treatments

Other: Placebo
Other: Resveratrol lipoic Acid

Study type

Interventional

Funder types

Other

Identifiers

NCT03062163
nanolab817

Details and patient eligibility

About

To evaluate the lipolysis effect of resveratrol and lipoic acid transdermal patch in overweight volunteers

Full description

66 participants with overweight received a resveratrol and lipoic acid transdermal patch treatment. The treatment areas have been treated including left and right arms. Subjects were evaluated using standardized measurements of body weight and circumference of arms at baseline and 2 weeks follow-up visits. Evaluation of physician were also measured.

Enrollment

66 patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy volunteers with BMI > 23

Exclusion criteria

  • resveratrol or lipoic acid allergies

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

66 participants in 2 patient groups

Resveratrol lipoic Acid
Experimental group
Description:
lipoic and resveratrol was loaded on the patch
Treatment:
Other: Resveratrol lipoic Acid
Placebo
Experimental group
Description:
normal saline was loaded on transdermal patch
Treatment:
Other: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems